Patent details
EP2833864
Title:
PHARMACEUTICAL FORMULATIONS COMPRISING CCR3 ANTAGONISTS
Basic Information
- Publication number:
- EP2833864
- PCT Application Number:
- EP2013056867
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP137146189
- PCT Publication Number:
- WO2013149987
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHARMACEUTICAL FORMULATIONS COMPRISING CCR3 ANTAGONISTS
- French Title of Invention:
- FORMULATIONS PHARMACEUTIQUES COMPRENANT DES ANTAGONISTES DE CCR3
- German Title of Invention:
- PHARMAZEUTISCHE FORMULIERUNGEN MIT CCR3-ANTAGONISTEN
- SPC Number:
-
Dates
- Filing date:
- 02/04/2013
- Grant date:
- 19/12/2018
- EP Publication Date:
- 11/02/2015
- PCT Publication Date:
- 10/10/2013
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 19/12/2018
- EP B1 Publication Date:
- 19/12/2018
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 02/04/2033
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 12/12/2018
-
-
- Name:
- Alkahest, Inc.
- Address:
- 125 Shoreway Road, Suite D, San Carlos, CA 94070, United States (US)
Agent
- Name:
- GRUND Intellectual Property Group
- From:
- 25/02/2019
- Address:
- Steinsdorfstrasse 2, 80538, MÜNCHEN, Germany (DE)
- To:
Inventor
1
- Name:
- FETSCHER, Alfred
- Address:
- Germany (DE)
2
- Name:
- SCHER, Jochen Matthias
- Address:
- Germany (DE)
Priority
- Priority Number:
- 12163078
- Priority Date:
- 04/04/2012
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
-
A61K 9/16;
A61K 9/20;
A61K 9/28;
A61K 9/48;
A61K 31/4545;
A61P 29/00;
Publication
European Patent Bulletin
1
- Issue number:
- 201851
- Publication date:
- 19/12/2018
- Description:
- Grant (B1)
2
- Issue number:
- 201904
- Publication date:
- 23/01/2019
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 30/04/2026
- Annual Fee Number:
- 14
- Annual Fee Amount:
- 198 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 17/04/2025
- Last Annual Fee Paid Number:
- 13
- Last Annual Fee Paid Amount:
- 180 Euro
- Payer:
- PAVIS PAYMENTS GMBH